(Q38965112)

8 September 2017

Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. (English)

1 reference

8 September 2017

1 reference

K M De Cock

1

1 reference

PubMed ID

7658822

8 September 2017

D Wilkinson

series ordinal

2

1 reference

PubMed ID

7658822

8 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

8 September 2017

1 reference

8 September 2017

346

1 reference

8 September 2017

675-677

1 reference

8 September 2017

8976

1 reference

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Directly observed treatment of tuberculosis. We can't afford not to try it

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

High-compliance tuberculosis treatment programme in a rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Case holding in patients with tuberculosis in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992284-9

7 January 2021

10.1016/S0140-6736(95)92284-9

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

7658822